临床药师对泛耐药鲍氏不动杆菌重症肺炎药学监护探讨
发布时间:2019-06-06 11:30
【摘要】:目的探讨临床药师参与重症肺炎患者药学监护的方法和作用,促进医院抗菌药物的合理应用。方法以2014年1月1例泛耐药鲍氏不动杆菌重症肺炎患者治疗为例,临床药师从制定个体化用药方案、提供用药依据、监测药物不良反应等,提供全程的药学监护,应用超常规剂量的替加环素治疗,并进行临床效果评价。结果临床药师积极参与药物治疗过程,对患者实施合理的药学监护,患者体温、血常规、C-反应蛋白等显著好转,两下肺病灶较前显著吸收,痰培养鲍氏不动杆菌为阴性,取得了满意的治疗效果。结论对重症肺炎患者开展药学监护非常必要,保证了患者治疗的安全性和有效性,有利于临床合理用药及医院整体用药水平的提高。
[Abstract]:Objective To study the methods and effects of clinical pharmacists in patients with severe pneumonia and to promote the rational application of antibiotics in hospital. Methods By taking the treatment of 1 January 2014 as an example, the clinical pharmacists provide the whole-course pharmaceutical monitoring from the development of the individualized drug administration scheme, provide the basis of the medication, monitor the adverse reaction of the drug, etc., and apply the supernormal dose of tigecycline for the treatment. And the clinical effect evaluation is carried out. Results The clinical pharmacists were actively involved in the drug treatment, and the patients were given reasonable pharmaceutical monitoring, the temperature of the patient, the blood routine, the C-reactive protein and the like improved significantly, and the lung lesions were significantly absorbed before the lung lesions, and the sputum culture of the Acinetobacter baumannii was negative, and the satisfactory therapeutic effect was obtained. Conclusion It is necessary to carry out the pharmaceutical care in the patients with severe pneumonia, and the safety and effectiveness of the patient's treatment are ensured, which is beneficial to the clinical rational use and the improvement of the overall drug level of the hospital.
【作者单位】: 郑州大学附属肿瘤医院;河南省肿瘤医院药学部;
【基金】:河南省医学科技基金资助项目(201304056)
【分类号】:R563.1
[Abstract]:Objective To study the methods and effects of clinical pharmacists in patients with severe pneumonia and to promote the rational application of antibiotics in hospital. Methods By taking the treatment of 1 January 2014 as an example, the clinical pharmacists provide the whole-course pharmaceutical monitoring from the development of the individualized drug administration scheme, provide the basis of the medication, monitor the adverse reaction of the drug, etc., and apply the supernormal dose of tigecycline for the treatment. And the clinical effect evaluation is carried out. Results The clinical pharmacists were actively involved in the drug treatment, and the patients were given reasonable pharmaceutical monitoring, the temperature of the patient, the blood routine, the C-reactive protein and the like improved significantly, and the lung lesions were significantly absorbed before the lung lesions, and the sputum culture of the Acinetobacter baumannii was negative, and the satisfactory therapeutic effect was obtained. Conclusion It is necessary to carry out the pharmaceutical care in the patients with severe pneumonia, and the safety and effectiveness of the patient's treatment are ensured, which is beneficial to the clinical rational use and the improvement of the overall drug level of the hospital.
【作者单位】: 郑州大学附属肿瘤医院;河南省肿瘤医院药学部;
【基金】:河南省医学科技基金资助项目(201304056)
【分类号】:R563.1
【参考文献】
相关期刊论文 前3条
1 章白苓;桂炳东;胡晓彦;胡龙华;贾坤如;;多重耐药鲍曼不动杆菌对替加环素等15种抗菌药物的耐药性分析[J];临床检验杂志;2011年07期
2 史煜波;董燕;;替加环素与多粘菌素B对泛耐药鲍曼不动杆菌体外研究[J];中国微生态学杂志;2010年09期
3 赵霞;王力红;张京利;马文晖;赵会杰;;多药耐药鲍氏不动杆菌的同源性鉴定与控制[J];中华医院感染学杂志;2012年12期
【共引文献】
相关期刊论文 前10条
1 刘锦容;张文炎;詹p茏,
本文编号:2494331
本文链接:https://www.wllwen.com/yixuelunwen/huxijib/2494331.html
最近更新
教材专著